Neurocrine Biosciences Inc (NBIX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$17.12B
EV to revenue ratio (TTM)
4.52
EV to ebitda
17.63
Financial Performance
Revenue (TTM)
$3.70B
Gross profit (TTM)
$2.39B
EBITDA
$1.07B
Profitability
Operating margin (TTM)
32.00%
Profit margin
19.00%
Return on assets (TTM)
12.40%
Return on equity (TTM)
20.40%
Per Share Metrics
Revenue per share (TTM)
$36.73
EPS
$6.75
Diluted EPS (TTM)
$6.75
Book value
$38.29
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
25.06
Trailing P/E
25.06
Forward P/E
16.53
PEG ratio
0.33
Price to sales ratio (TTM)
4.63
Price to book ratio (TTM)
4.41
Growth
Quarterly earnings growth (YoY)
41.20%
Quarterly revenue growth (YoY)
-3.90%
Analyst Sentiment
Strong buy
4
Buy
21
Hold
4
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.33